Among 191 cannabis users in a controlled trial, oral fluid THC at 10 ng/mL was the most promising biomarker for identifying use within 3 hours, outperforming blood and breath measures.
Forensic toxicologists, law enforcement, and policymakers developing cannabis-impaired driving testing protocols.
Oral fluid THC 10 ng/mL: 99.7% specificity, 82.4% sensitivity for 3-hour window
What the researchers found
Oral fluid THC at 10 ng/mL cutoff showed 99.7% specificity, 82.4% sensitivity, 92.5% positive predictive value, and 99.2% negative predictive value for detecting cannabis use within 3 hours. Frequent users had residual THC in blood but not oral fluid before smoking, making oral fluid less prone to false positives from prior-day use. Blood CBN at 1 ng/mL had 100% positive predictive value but only 31.4% sensitivity.
Why it matters
Proving cannabis-impaired driving requires a biomarker that can reliably distinguish recent use from residual detection. This study provides the most comprehensive comparison of blood, oral fluid, and breath for this purpose.
The numbers in context
191 users. Oral fluid THC 10 ng/mL: 99.7% specificity, 82.4% sensitivity. Blood CBN 1 ng/mL: 100% specificity, 31.4% sensitivity. Frequent users had residual blood THC before smoking but not residual oral fluid THC. At 4.3% prevalence: OF THC 92.5% PPV, 99.2% NPV.
How the study worked
Randomized trial with 191 frequent and occasional cannabis users who smoked placebo, 5.9%, or 13.4% THC cannabis. Blood, oral fluid, and breath collected before and up to 6 hours after smoking. Receiver operating characteristic analysis identified optimal biomarker cutoffs for recent use detection.
What this study cannot tell us
Only smoked cannabis tested. Oral fluid THC at 10 ng/mL still detectable in 23% at 4.4 hours, limiting late specificity. Cannabis impairment does not correlate linearly with THC concentrations. Lab setting may not reflect real-world conditions.
How to read the evidence
Well-designed controlled trial with adequate sample size and gold-standard analytical methods.
When this study was published
2021 controlled dosing study.
The bigger picture
No biomarker equates to impairment, but oral fluid THC comes closest to identifying recent intake. The lack of residual oral fluid THC in frequent users (unlike blood) makes it a fairer testing medium that does not penalize chronic users for prior-day use.
Questions still open
- Would oral fluid testing perform similarly after edible consumption? Can combining oral fluid THC with behavioral tests improve accuracy? Should roadside testing programs shift from blood to oral fluid?
Common questions
Is oral fluid better than blood for cannabis testing?
Does testing positive mean being impaired?
Read the original research
Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath.
Journal of analytical toxicology, 45(8), 820-828
Citation
Hubbard, J A; Hoffman, M A; Ellis, S E; Sobolesky, P M; Smith, B E; Suhandynata, R T; Sones, E G; Sanford, S K; Umlauf, A; Huestis, M A; Grelotti, D J; Grant, I; Marcotte, T D; Fitzgerald, R L. (2021). Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath.. Journal of analytical toxicology, 45(8), 820-828. https://doi.org/10.1093/jat/bkab080